전립선암(Prostate Cancer) 정밀 패널
전립선 암은 피부암 다음으로 남성에게서 두 번째로 흔한 암이며 폐암 다음으로 남성 암 사망의 두 번째 주요 원인입니다. 전립선 암의 위험 요소에는 연령 증가, 가족력 및 흑인 인종이 있습니다.

이 패널의 임상적 유용성은 다음과 같습니다.
National Comprehensive Cancer Network. (2021). Retrievedfrom https://www.nccn.org/professionals/physician_gls/default.aspx#detection
Zhen, J. T., Syed, J., Nguyen, K. A., Leapman, M. S., Agarwal, N., Brierley, K., Llor, X., Hofstatter, E., &Shuch, B. (2018). Genetic testing for hereditary prostate cancer: Current status and limitations. Cancer, 124(15), 3105–3117. https://doi.org/10.1002/cncr.31316
Heidegger, I., Tsaur, I., Borgmann, H., Surcel, C., Kretschmer, A., Mathieu, R., Visschere, P., Valerio, M., van den Bergh, R., Ost, P., Tilki, D., Gandaglia, G., Ploussard, G., & EAU-YAU Prostate Cancer Working Party (2019). Hereditary prostate cancer – Primetime for genetic testing?. Cancer treatment reviews, 81, 101927. https://doi.org/10.1016/j.ctrv.2019.101927
Pilarski R. (2019). The Role of BRCATesting in Hereditary Pancreatic and Prostate Cancer Families. American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting, 39, 79–86. https://doi.org/10.1200/EDBK_238977
Tan, S. H., Petrovics, G., &Srivastava, S. (2018). Prostate Cancer Genomics: Recent Advances and the Prevailing Underrepresentation from Racial and Ethnic Minorities. International journal of molecular sciences, 19(4), 1255. https://doi.org/10.3390/ijms19041255
Heise, M., & Haus, O. (2014). Dziedzicznyrakgruczołukrokowego [Hereditary prostate cancer]. Postepyhigieny i medycynydoswiadczalnej (Online), 68, 653–665. https://doi.org/10.5604/17322693.1104682
Pritzlaff, M., Tian, Y., Reineke, P., Stuenkel, A. J., Allen, K., Gutierrez, S., Jackson, M., Dolinsky, J. S., LaDuca, H., Xu, J., Black, M. H., & Helfand, B. T. (2020). Diagnosing hereditary cancer predisposition in men with prostate cancer. Genetics in medicine : official journal of the American College of Medical Genetics, 22(9), 1517–1523. https://doi.org/10.1038/s41436-020-0830-5